Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Methylphenobarbitone poisoning |
Causative agent (attribute) |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Accidental methylphenobarbitone poisoning |
Causative agent (attribute) |
False |
Methylphenobarbital |
Inferred relationship |
Some |
|
Intentional methylphenobarbitone poisoning |
Causative agent (attribute) |
False |
Methylphenobarbital |
Inferred relationship |
Some |
|
Methylphenobarbitone poisoning of undetermined intent |
Causative agent (attribute) |
False |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Methylphenobarbitone adverse reaction |
Causative agent (attribute) |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Allergy to mephobarbital |
Causative agent (attribute) |
False |
Methylphenobarbital |
Inferred relationship |
Some |
|
Methylphenobarbitone overdose (disorder) |
Causative agent (attribute) |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Accidental methylphenobarbitone overdose |
Causative agent (attribute) |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Intentional methylphenobarbitone overdose |
Causative agent (attribute) |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Methylphenobarbitone overdose of undetermined intent |
Causative agent (attribute) |
False |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Methylphenobarbital 32 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenobarbital |
Inferred relationship |
Some |
|
Methylphenobarbital 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenobarbital |
Inferred relationship |
Some |
|
Methylphenobarbital 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenobarbital |
Inferred relationship |
Some |
|
Product containing methylphenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Mephobarbital measurement |
Component |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Accidental methylphenobarbitone poisoning |
Causative agent (attribute) |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Intentional methylphenobarbitone poisoning |
Causative agent (attribute) |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Allergy to mephobarbital |
Causative agent (attribute) |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Methylphenobarbital 32 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Methylphenobarbital 32 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Methylphenobarbital 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Methylphenobarbital 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Methylphenobarbital 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Methylphenobarbital 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Methylphenobarbital 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Methylphenobarbital 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Methylphenobarbital 32 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Methylphenobarbital-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Product containing only methylphenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |
Methylphenobarbital only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylphenobarbital |
Inferred relationship |
Some |
1 |